rs147222357
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000213.5(ITGB4):c.3793+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000213.5 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB4 | NM_000213.5 | c.3793+1G>A | splice_donor_variant | ENST00000200181.8 | NP_000204.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB4 | ENST00000200181.8 | c.3793+1G>A | splice_donor_variant | 1 | NM_000213.5 | ENSP00000200181 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250218Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135400
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460722Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 726686
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2023 | This variant is present in population databases (rs147222357, gnomAD 0.002%). This sequence change affects a donor splice site in intron 30 of the ITGB4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ITGB4 are known to be pathogenic (PMID: 11328943, 16473856). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 14736). Disruption of this splice site has been observed in individuals with epidermolysis bullosa (PMID: 33937469, 34046686). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 01, 2018 | The c.3793+1G>A: IVS30+1G>A pathogenic variant in the ITGB4 gene has been reported previously in association with EB-PA (Pulkkinen et al. 1997 Mellerio et al., 1998, Ashton et al., 2001, Varki et al., 2006, Dang et al. 2008, Lee et al. 2015). Pulkkinen et al. 1997 showed that the variant leads to the use of a cryptic splice site and results in a frameshift and the creation of a downstream STOP codon resulting in premature termination of the protein and when present in the homozygous state results in a severe phenotype (Dang et al., 2008). This splice site variant destroys the canonical splice donor site in intron 30. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.3793+1G>A: IVS30+1G>A variant was not observed in significant numbers in approximately 8600 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.3793+1G>A: IVS30+1G>A as a pathogenic variant. - |
Junctional epidermolysis bullosa with pyloric atresia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1998 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at